| Musculoskeletal system | |||||
|---|---|---|---|---|---|
| Musculoskeletal system / Pain and inflammation in musculoskeletal disorders | |||||
| aceclofenac | Not approved for prescribing | ||||
| Oral tablet | |||||
| Aceclofenac (Non-proprietary) | |||||
| Preservex (Almirall Ltd) | |||||
| aspirin | |||||
| Dispersible tablet | |||||
| Aspirin (Non-proprietary) | |||||
| Disprin (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Gastro-resistant tablet | |||||
| Aspirin (Non-proprietary) | |||||
| Nu-Seals (Alliance Pharmaceuticals Ltd) | |||||
| Suppository | |||||
| Aspirin (Non-proprietary) | |||||
| Oral tablet | |||||
| Aspirin (Non-proprietary) | |||||
| celecoxib | Not approved for prescribing | ||||
| Oral capsule | |||||
| Celecoxib (Non-proprietary) | |||||
| Celebrex (Viatris UK Healthcare Ltd) | |||||
| dexketoprofen | Not approved for prescribing | ||||
| Oral tablet | |||||
| Keral (A. Menarini Farmaceutica Internazionale SRL) | |||||
| diclofenac potassium | Not approved for prescribing | ||||
| Oral tablet | |||||
| Diclofenac potassium (Non-proprietary) | |||||
| Voltarol Rapid (Novartis Pharmaceuticals UK Ltd) | |||||
| diclofenac sodium | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Diclo-SR (Strides Pharma UK Ltd) | |||||
| Dicloflex 75mg SR (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Dicloflex Retard (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Gastro-resistant tablet | |||||
| Diclofenac sodium (Non-proprietary) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Diclomax Retard (Galen Ltd) | Not approved for prescribing | ||||
| Diclomax SR (Galen Ltd) | Not approved for prescribing | ||||
| Motifene (Glenwood GmbH) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Akis (Flynn Pharma Ltd) | Hospital only | ||||
| Voltarol (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| Eye drops | |||||
| Voltarol Ophtha (Thea Pharmaceuticals Ltd) | |||||
| Voltarol Ophtha Multidose (Thea Pharmaceuticals Ltd) | |||||
| Suppository | |||||
| Econac (Advanz Pharma) | Specialist knowledge/initiation | ||||
| Voltarol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Cutaneous gel | |||||
| Diclofenac sodium (Non-proprietary) | |||||
| Solaraze (Almirall Ltd) | |||||
| Voltarol Emulgel (Haleon UK Ltd) | |||||
| diclofenac sodium with misoprostol | Not approved for prescribing | ||||
| Gastro-resistant tablet | |||||
| Arthrotec (Pfizer Ltd) | Not approved for prescribing | ||||
| etodolac | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Etolyn (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Etopan XL (Sun Pharma UK Ltd) | Not approved for prescribing | ||||
| Lodine SR (Almirall Ltd) | Not approved for prescribing | ||||
| etoricoxib | Specialist knowledge/initiation | ||||
| Oral tablet | |||||
| Etoricoxib (Non-proprietary) | |||||
| Arcoxia (Organon Pharma (UK) Ltd) | |||||
| felbinac | Not approved for prescribing | ||||
| flurbiprofen | Not approved for prescribing | ||||
| Lozenge | |||||
| Strefen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Eye drops | |||||
| Ocufen (AbbVie Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Flurbiprofen (Non-proprietary) | |||||
| ibuprofen | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Brufen Retard (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Chewable capsule | |||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Modified-release capsule | |||||
| Ibuprofen (Non-proprietary) | Not approved for prescribing | ||||
| Galprofen Long Lasting (Galpharm International Ltd) | |||||
| Nurofen Long Lasting (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Effervescent granules | |||||
| Brufen (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Oral suspension | |||||
| Ibuprofen (Non-proprietary) | Joint formulary choice | ||||
| Brufen (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
|
Prescribe generically
. |
|||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
|
Prescribe generically
. |
|||||
| Solution for infusion | |||||
| Ibuprofen (Non-proprietary) | |||||
| Pedea (Recordati Rare Diseases UK Ltd) | |||||
| Oral tablet | |||||
| Ibuprofen (Non-proprietary) | |||||
| Brufen (Viatris UK Healthcare Ltd) | |||||
| Feminax Express (Bayer Plc) | |||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Nurofen Express (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Nurofen Joint & Back Pain Relief (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Nurofen Migraine Pain (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Oral capsule | |||||
| Ibuprofen (Non-proprietary) | |||||
| Flarin (infirst Ltd) | |||||
| Nurofen Express (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Cutaneous gel | |||||
| Ibuprofen (Non-proprietary) | Joint formulary choice | ||||
| Ibugel (Dermal Laboratories Ltd) | |||||
| Ibuleve (Diomed Developments Ltd) | |||||
| Phorpain (Advanz Pharma) | |||||
| indometacin | Joint formulary choice | ||||
| Suppository | |||||
| Indometacin (Non-proprietary) | |||||
| Oral capsule | |||||
| Indometacin (Non-proprietary) | |||||
| ketoprofen | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Oruvail (Sanofi) | Not approved for prescribing | ||||
| Cutaneous gel | |||||
| Ketoprofen (Non-proprietary) | |||||
| Powergel (A. Menarini Farmaceutica Internazionale SRL) | |||||
| Tiloket (Tillomed Laboratories Ltd) | |||||
| mefenamic acid | Joint formulary choice | ||||
| Oral suspension | |||||
| Mefenamic acid (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Mefenamic acid (Non-proprietary) | |||||
| Ponstan (Essential Generics Ltd) | |||||
| Oral capsule | |||||
| Mefenamic acid (Non-proprietary) | |||||
| Ponstan (Essential Generics Ltd) | |||||
| meloxicam | Not approved for prescribing | ||||
| Orodispersible tablet | |||||
| Meloxicam (Non-proprietary) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Meloxicam (Non-proprietary) | |||||
| nabumetone | Not approved for prescribing | ||||
| Oral tablet | |||||
| Nabumetone (Non-proprietary) | |||||
| naproxen | Joint formulary choice | ||||
| Effervescent tablet | |||||
| Stirlescent (Stirling Anglian Pharmaceuticals Ltd) | |||||
| Gastro-resistant tablet | |||||
| Naproxen (Non-proprietary) | Joint formulary choice | ||||
| Naprosyn EC (Atnahs Pharma UK Ltd) | Joint formulary choice | ||||
| Nexocin EC (Noumed Life Sciences Ltd) | |||||
| Oral suspension | |||||
| Naproxen (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Naproxen (Non-proprietary) | |||||
| Naprosyn (Atnahs Pharma UK Ltd) | |||||
| naproxen with esomeprazole | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Vimovo (Grunenthal Ltd) | Not approved for prescribing | ||||
| piroxicam | Joint formulary choice | ||||
|
Oral piroxicam is not approved for prescribing
Piroxicam capsules and oral dispersible tablets are not approved for prescribing. Topical piroxicam can be prescribed for pain. |
|||||
| Orodispersible tablet | |||||
| Feldene Melt (Pfizer Ltd) | Not approved for prescribing | ||||
| Oral capsule | |||||
| Piroxicam (Non-proprietary) | |||||
| Feldene (Pfizer Ltd) | |||||
| Cutaneous gel | |||||
| Piroxicam (Non-proprietary) | |||||
| sulindac | Not approved for prescribing | ||||
| Oral tablet | |||||
| Sulindac (Non-proprietary) | |||||
| tenoxicam | Not approved for prescribing | ||||
| tiaprofenic acid | Not approved for prescribing | ||||
| Oral tablet | |||||
| Surgam (Beaumont Pharma Ltd) | |||||
| tramadol with dexketoprofen | Not approved for prescribing | ||||
| Oral tablet | |||||
| Skudexa (A. Menarini Farmaceutica Internazionale SRL) | |||||
| Musculoskeletal system / Soft tissue and joint disorders | |||||
| AUTOLOGOUS CHONDROCYTE IMPLANTATION | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Musculoskeletal system / Local inflammation of joints and soft tissue | |||||
| dexamethasone | Not approved for prescribing |
NICE TA229 NICE TA824 NICE TA460 |
|||
| Soluble tablet | |||||
| Dexamethasone (Non-proprietary) | |||||
| Glensoludex (Glenmark Pharmaceuticals Europe Ltd) | |||||
| Oral solution | |||||
| Dexamethasone (Non-proprietary) | |||||
| Dexsol (Rosemont Pharmaceuticals Ltd) | |||||
| Solution for injection | |||||
| Dexamethasone (Non-proprietary) | |||||
| Eye drops | |||||
| Dexamethasone (Non-proprietary) | |||||
| Dexafree (Thea Pharmaceuticals Ltd) | |||||
| Dropodex (Rayner Pharmaceuticals Ltd) | |||||
| Etacortilen (Nordic Pharma Ltd) | |||||
| Eythalm (Aspire Pharma Ltd) | |||||
| Maxidex (Novartis Pharmaceuticals UK Ltd) | |||||
| Puradex (Aspire Pharma Ltd) | |||||
| Oral tablet | |||||
| Dexamethasone (Non-proprietary) | |||||
| Prolonged-release intravitreal implant | |||||
| Ozurdex (AbbVie Ltd) | |||||
| hydrocortisone | Specialist knowledge/initiation | ||||
| Soluble tablet | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Muco-adhesive buccal tablet | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Modified-release tablet | |||||
| Plenadren (Takeda UK Ltd) | |||||
| Modified-release capsule | |||||
| Efmody (Diurnal Ltd) | |||||
| Oral solution | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Solution for injection | |||||
| Hydrocortisone (Non-proprietary) | Specialist knowledge/initiation | ||||
| Powder for solution for injection | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Solu-Cortef (Pfizer Ltd) | |||||
| Powder and solvent for solution for injection | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Solu-Cortef (Pfizer Ltd) | |||||
| Eye drops | |||||
| Softacort (Thea Pharmaceuticals Ltd) | |||||
| Oral tablet | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Hydventia (OcXia) | |||||
| Cutaneous ointment | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Oral granules | |||||
| Alkindi (Diurnal Ltd) | |||||
| Cutaneous cream | |||||
| Hydrocortisone (Non-proprietary) | |||||
| Dermacort (Marlborough Pharmaceuticals Ltd) | |||||
| Hc45 (Karo Healthcare UK Ltd) | |||||
| methylprednisolone | Specialist knowledge/initiation | ||||
| Powder and solvent for solution for injection | |||||
| Methylprednisolone (Non-proprietary) | |||||
| Solu-Medrone (Pfizer Ltd) | |||||
| Suspension for injection | |||||
| Depo-Medrone (Pfizer Ltd) | Specialist knowledge/initiation | ||||
| Oral tablet | |||||
| Medrone (Pfizer Ltd) | |||||
| methylprednisolone with lidocaine | Not approved for prescribing | ||||
| Suspension for injection | |||||
| Depo-Medrone with Lidocaine (Pfizer Ltd) | Not approved for prescribing | ||||
| prednisolone | Joint formulary choice | ||||
| Soluble tablet | |||||
| Prednisolone (Non-proprietary) | |||||
| Gastro-resistant tablet | |||||
| Prednisolone (Non-proprietary) | Not approved for prescribing | ||||
| Dilacort (Crescent Pharma Ltd) | Not approved for prescribing | ||||
| Oral solution | |||||
| Prednisolone (Non-proprietary) | Joint formulary choice | ||||
| Ear/eye drops solution | |||||
| Prednisolone (Non-proprietary) | |||||
| Eye drops | |||||
| Prednisolone (Non-proprietary) | |||||
| Pred Forte (AbbVie Ltd) | |||||
| Suppository | |||||
| Prednisolone (Non-proprietary) | |||||
| Enema | |||||
| Prednisolone (Non-proprietary) | |||||
| Oral tablet | |||||
| Prednisolone (Non-proprietary) | |||||
| Rectal foam | |||||
| Prednisolone (Non-proprietary) | |||||
| triamcinolone acetonide | Specialist knowledge/initiation | ||||
| Suspension for injection | |||||
| Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Spray | |||||
| Nasacort (Sanofi Consumer Healthcare) | |||||
| triamcinolone hexacetonide | Not approved for prescribing | ||||
| Suspension for injection | |||||
| Triamcinolone hexacetonide (Non-proprietary) | Not approved for prescribing | ||||
| Musculoskeletal system / Soft tissue disorders | |||||
| hyaluronidase | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Hyaluronidase (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Musculoskeletal system / Hyperuricaemia and gout | |||||
| Lesinurad | Not approved for prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| allopurinol | Joint formulary choice | ||||
| Oral tablet | |||||
| Allopurinol (Non-proprietary) | |||||
| Zyloric (Aspen Pharma Trading Ltd) | |||||
| canakinumab | Not approved for prescribing | ||||
| Solution for injection | |||||
| Ilaris (Novartis Pharmaceuticals UK Ltd) | |||||
| colchicine | Joint formulary choice | ||||
| Oral tablet | |||||
| Colchicine (Non-proprietary) | |||||
| diclofenac potassium | Not approved for prescribing | ||||
| Oral tablet | |||||
| Diclofenac potassium (Non-proprietary) | |||||
| Voltarol Rapid (Novartis Pharmaceuticals UK Ltd) | |||||
| diclofenac sodium | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Diclo-SR (Strides Pharma UK Ltd) | |||||
| Dicloflex 75mg SR (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Dicloflex Retard (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Gastro-resistant tablet | |||||
| Diclofenac sodium (Non-proprietary) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Diclomax Retard (Galen Ltd) | Not approved for prescribing | ||||
| Diclomax SR (Galen Ltd) | Not approved for prescribing | ||||
| Motifene (Glenwood GmbH) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Akis (Flynn Pharma Ltd) | |||||
| Voltarol (Novartis Pharmaceuticals UK Ltd) | |||||
| Eye drops | |||||
| Voltarol Ophtha (Thea Pharmaceuticals Ltd) | |||||
| Voltarol Ophtha Multidose (Thea Pharmaceuticals Ltd) | |||||
| Suppository | |||||
| Econac (Advanz Pharma) | Specialist knowledge/initiation | ||||
| Voltarol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Cutaneous gel | |||||
| Diclofenac sodium (Non-proprietary) | |||||
| Solaraze (Almirall Ltd) | |||||
| Voltarol Emulgel (Haleon UK Ltd) | |||||
| etoricoxib | Specialist knowledge/initiation | ||||
| Oral tablet | |||||
| Etoricoxib (Non-proprietary) | |||||
| Arcoxia (Organon Pharma (UK) Ltd) | |||||
| febuxostat | Specialist knowledge/initiation |
NICE TA164 |
|||
| Oral tablet | |||||
| Febuxostat (Non-proprietary) | |||||
| Adenuric (A. Menarini Farmaceutica Internazionale SRL) | |||||
| Elstabya (Amarox Ltd) | |||||
| indometacin | Joint formulary choice | ||||
| Suppository | |||||
| Indometacin (Non-proprietary) | |||||
| Oral capsule | |||||
| Indometacin (Non-proprietary) | |||||
| ketoprofen | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Oruvail (Sanofi) | Not approved for prescribing | ||||
| Cutaneous gel | |||||
| Ketoprofen (Non-proprietary) | |||||
| Powergel (A. Menarini Farmaceutica Internazionale SRL) | |||||
| Tiloket (Tillomed Laboratories Ltd) | |||||
| naproxen | Joint formulary choice | ||||
| Effervescent tablet | |||||
| Stirlescent (Stirling Anglian Pharmaceuticals Ltd) | |||||
| Gastro-resistant tablet | |||||
| Naproxen (Non-proprietary) | Joint formulary choice | ||||
| Naprosyn EC (Atnahs Pharma UK Ltd) | Joint formulary choice | ||||
| Nexocin EC (Noumed Life Sciences Ltd) | |||||
| Oral suspension | |||||
| Naproxen (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Naproxen (Non-proprietary) | |||||
| Naprosyn (Atnahs Pharma UK Ltd) | |||||
| naproxen with esomeprazole | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Vimovo (Grunenthal Ltd) | Not approved for prescribing | ||||
| sulindac | Not approved for prescribing | ||||
| Oral tablet | |||||
| Sulindac (Non-proprietary) | |||||
| Musculoskeletal system / Arthritis | |||||
| abatacept | Hospital only |
NICE TA195 NICE TA375 NICE TA715 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Orencia (Bristol-Myers Squibb Pharmaceuticals Ltd, Imported (Germany)) | Hospital only | ||||
| Orencia ClickJect (Bristol-Myers Squibb Pharmaceuticals Ltd) | Hospital only | ||||
| Powder for solution for infusion | |||||
| Orencia (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
| aceclofenac | Not approved for prescribing | ||||
| Oral tablet | |||||
| Aceclofenac (Non-proprietary) | |||||
| Preservex (Almirall Ltd) | |||||
| adalimumab | Hospital only |
NICE TA187 NICE TA329 NICE TA199 NICE TA195 NICE TA375 NICE TA715 NICE TA383 NICE TA392 NICE TA146 NICE TA460 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Adalimumab (Non-proprietary) | |||||
| Amgevita (Amgen Ltd) | |||||
| Humira (AbbVie Ltd) | Hospital only | ||||
|
ADALIMUMAB
Dose escalation of Adalimumab is approved for Crohn's disease and ulcerative colitis |
|||||
| Hyrimoz (Sandoz Ltd) | |||||
| Idacio (Fresenius Kabi Ltd) | |||||
| Imraldi (Biogen Idec Ltd) | |||||
| Yuflyma (Celltrion Healthcare UK Ltd) | |||||
| anakinra | Hospital only |
NICE TA685 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Kineret (Swedish Orphan Biovitrum Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| apremilast | Hospital only |
NICE TA433 NICE TA419 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Form unstated | |||||
| Otezla (Amgen Ltd) | |||||
| Oral tablet | |||||
| Otezla (Amgen Ltd) | |||||
| azathioprine | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral suspension | |||||
| Jayempi (Nova Laboratories Ltd) | |||||
| Oral tablet | |||||
| Azathioprine (Non-proprietary) | |||||
| Imuran (Aspen Pharma Trading Ltd) | |||||
| baricitinib | Hospital only |
NICE TA466 NICE TA681 NICE TA926 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Oral tablet | |||||
| Olumiant (Eli Lilly and Company Ltd) | |||||
| bimekizumab | Hospital only |
NICE TA723 NICE TA916 NICE TA918 |
|||
| Solution for injection | |||||
| Bimzelx (UCB Pharma Ltd) | Hospital only | ||||
| capsaicin | Not approved for prescribing | ||||
| Cutaneous patch | |||||
| Qutenza (Grunenthal Ltd) | |||||
| Cutaneous cream | |||||
| Capsaicin (Non-proprietary) | |||||
| celecoxib | Not approved for prescribing | ||||
| Oral capsule | |||||
| Celecoxib (Non-proprietary) | |||||
| Celebrex (Viatris UK Healthcare Ltd) | |||||
| certolizumab pegol | Hospital only |
NICE TA375 NICE TA383 NICE TA415 NICE TA445 NICE TA574 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Cimzia (UCB Pharma Ltd) | Hospital only | ||||
| chloroquine | Hospital only | ||||
|
Prescribing of chloroquine for travelling purposes
Chloroquine for malaria prophylaxis should not be issued on an NHS prescription. Patients should be prescribed this on a private prescription for travelling purposes. |
|||||
| Oral solution | |||||
| Malarivon (Wallace Manufacturing Chemists Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Avloclor (Alliance Pharmaceuticals Ltd) | |||||
| ciclosporin | Shared care guideline |
NICE TA369 |
|||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral solution | |||||
| Neoral (Novartis Pharmaceuticals UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Solution for infusion | |||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| Eye drops | |||||
| Ikervis (Santen UK Ltd) | |||||
| Verkazia (Santen UK Ltd) | |||||
| Oral capsule | |||||
| Ciclosporin (Non-proprietary) | |||||
| Capimune (Viatris UK Healthcare Ltd) | |||||
| Capsorin (Morningside Healthcare Ltd) | |||||
| Deximune (Dexcel-Pharma Ltd) | |||||
| Neoral (Novartis Pharmaceuticals UK Ltd) | |||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | |||||
| Vanquoral (Teva UK Ltd) | |||||
| cyclophosphamide | Hospital only | ||||
| Powder for solution for injection | |||||
| Cyclophosphamide (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Cyclophosphamide (Non-proprietary) | |||||
| Cytoxan (Imported (United States)) | |||||
| diclofenac potassium | Not approved for prescribing | ||||
| Oral tablet | |||||
| Diclofenac potassium (Non-proprietary) | |||||
| Voltarol Rapid (Novartis Pharmaceuticals UK Ltd) | |||||
| diclofenac sodium | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Diclo-SR (Strides Pharma UK Ltd) | |||||
| Dicloflex 75mg SR (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Dicloflex Retard (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
| Gastro-resistant tablet | |||||
| Diclofenac sodium (Non-proprietary) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Diclomax Retard (Galen Ltd) | Not approved for prescribing | ||||
| Diclomax SR (Galen Ltd) | Not approved for prescribing | ||||
| Motifene (Glenwood GmbH) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Akis (Flynn Pharma Ltd) | |||||
| Voltarol (Novartis Pharmaceuticals UK Ltd) | |||||
| Eye drops | |||||
| Voltarol Ophtha (Thea Pharmaceuticals Ltd) | |||||
| Voltarol Ophtha Multidose (Thea Pharmaceuticals Ltd) | |||||
| Suppository | |||||
| Econac (Advanz Pharma) | Specialist knowledge/initiation | ||||
| Voltarol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Cutaneous gel | |||||
| Diclofenac sodium (Non-proprietary) | |||||
| Solaraze (Almirall Ltd) | |||||
| Voltarol Emulgel (Haleon UK Ltd) | |||||
| etanercept | Hospital only |
NICE TA103 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA383 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Biosimilar preparation is available for this
Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept |
|||||
| Solution for injection | |||||
| Benepali (Biogen Idec Ltd) | Hospital only | ||||
|
Biosimilar preparation is available for this
Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept |
|||||
| Enbrel (Pfizer Ltd) | Hospital only | ||||
|
Biosimilar preparation is available for this
Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept |
|||||
| Enbrel MyClic (Pfizer Ltd) | Hospital only | ||||
|
Biosimilar preparation is available for this
Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept |
|||||
| Erelzi (Sandoz Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Biosimilar preparation is available for this
Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept |
|||||
| Powder and solvent for solution for injection | |||||
| Enbrel (Pfizer Ltd) | Hospital only | ||||
|
Biosimilar preparation is available for this
Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept |
|||||
| etodolac | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Etolyn (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Etopan XL (Sun Pharma UK Ltd) | Not approved for prescribing | ||||
| Lodine SR (Almirall Ltd) | Not approved for prescribing | ||||
| etoricoxib | Specialist knowledge/initiation | ||||
| Oral tablet | |||||
| Etoricoxib (Non-proprietary) | |||||
| Arcoxia (Organon Pharma (UK) Ltd) | |||||
| filgotinib | Hospital only |
NICE TA676 NICE TA792 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
The Joint Prescribing Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Oral tablet | |||||
| Jyseleca (Galapagos Biotech Ltd) | Hospital only | ||||
| flurbiprofen | Not approved for prescribing | ||||
| Lozenge | |||||
| Strefen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Eye drops | |||||
| Ocufen (AbbVie Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Flurbiprofen (Non-proprietary) | |||||
| glucosamine | Not approved for prescribing | ||||
| Oral tablet | |||||
| Glucosamine (Non-proprietary) | |||||
| Gosa-S (Ennogen Healthcare Ltd) | |||||
| Gosaveg (Ennogen Healthcare Ltd) | |||||
| golimumab | Hospital only |
NICE TA220 NICE TA375 NICE TA225 NICE TA383 NICE TA497 NICE TA329 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Simponi (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
|
GOLIMUMAB
The JPG agreed to approve this medicine for use at Homerton University Hospital, Foundation Trust provided it is used in accordance with the relevant NICE TA(s). |
|||||
| guselkumab | Hospital only |
NICE TA521 NICE TA815 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Tremfya (Janssen-Cilag Ltd) | Hospital only | ||||
| hydroxychloroquine sulfate | Shared care guideline | ||||
|
HYDROXYCHLOROQUINE SULFATE
A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including prescribing. Click here to access the Shared Care Guideline for hydroxychloroquine
|
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral tablet | |||||
| Hydroxychloroquine sulfate (Non-proprietary) | |||||
| Quinoric (Bristol Laboratories Ltd) | |||||
| ibuprofen | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Brufen Retard (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Chewable capsule | |||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Modified-release capsule | |||||
| Ibuprofen (Non-proprietary) | Not approved for prescribing | ||||
| Galprofen Long Lasting (Galpharm International Ltd) | |||||
| Nurofen Long Lasting (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Effervescent granules | |||||
| Brufen (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Oral suspension | |||||
| Ibuprofen (Non-proprietary) | Joint formulary choice | ||||
| Brufen (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| Solution for infusion | |||||
| Ibuprofen (Non-proprietary) | |||||
| Pedea (Recordati Rare Diseases UK Ltd) | |||||
| Oral tablet | |||||
| Ibuprofen (Non-proprietary) | |||||
| Brufen (Viatris UK Healthcare Ltd) | |||||
| Feminax Express (Bayer Plc) | |||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Nurofen Express (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Nurofen Joint & Back Pain Relief (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Nurofen Migraine Pain (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Oral capsule | |||||
| Ibuprofen (Non-proprietary) | |||||
| Flarin (infirst Ltd) | |||||
| Nurofen Express (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
| Cutaneous gel | |||||
| Ibuprofen (Non-proprietary) | |||||
| Ibugel (Dermal Laboratories Ltd) | |||||
| Ibuleve (Diomed Developments Ltd) | |||||
| Phorpain (Advanz Pharma) | |||||
| indometacin | Joint formulary choice | ||||
| Suppository | |||||
| Indometacin (Non-proprietary) | |||||
| Oral capsule | |||||
| Indometacin (Non-proprietary) | |||||
| infliximab | Hospital only |
NICE TA134 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA187 NICE TA163 NICE TA329 NICE TA383 |
|||
|
Biosimilar
Remsima® (biosimilar infliximab) is the formulary choice brand for infliximab. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Remsima (Celltrion Healthcare UK Ltd) | Hospital only | ||||
| Powder for solution for infusion | |||||
| Flixabi (Biogen Idec Ltd) | |||||
| Inflectra (Pfizer Ltd) | |||||
| Remicade (Merck Sharp & Dohme (UK) Ltd) | |||||
| Remsima (Celltrion Healthcare UK Ltd) | |||||
| Zessly (Sandoz Ltd) | |||||
| ixekizumab | Hospital only |
NICE TA442 NICE TA537 NICE TA718 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Taltz (Eli Lilly and Company Ltd) | Hospital only | ||||
| ketoprofen | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Oruvail (Sanofi) | Not approved for prescribing | ||||
| Cutaneous gel | |||||
| Ketoprofen (Non-proprietary) | |||||
| Powergel (A. Menarini Farmaceutica Internazionale SRL) | |||||
| Tiloket (Tillomed Laboratories Ltd) | |||||
| leflunomide | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral tablet | |||||
| Leflunomide (Non-proprietary) | |||||
| Arava (Sanofi) | |||||
| mefenamic acid | Joint formulary choice | ||||
| Oral suspension | |||||
| Mefenamic acid (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Mefenamic acid (Non-proprietary) | |||||
| Ponstan (Essential Generics Ltd) | |||||
| Oral capsule | |||||
| Mefenamic acid (Non-proprietary) | |||||
| Ponstan (Essential Generics Ltd) | |||||
| meloxicam | Not approved for prescribing | ||||
| Orodispersible tablet | |||||
| Meloxicam (Non-proprietary) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Meloxicam (Non-proprietary) | |||||
| methotrexate | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral solution | |||||
| Methotrexate (Non-proprietary) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Jylamvo (Esteve Pharmaceuticals Ltd) | |||||
| Solution for injection | |||||
| Methotrexate (Non-proprietary) | Hospital only | ||||
| Methofill (Accord-UK Ltd) | |||||
| Metoject PEN (medac UK) | Hospital only | ||||
| Nordimet (Nordic Pharma Ltd) | Hospital only | ||||
| Zlatal (Nordic Pharma Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Methotrexate (Non-proprietary) | Hospital only | ||||
| Oral tablet | |||||
| Methotrexate (Non-proprietary) | |||||
| Maxtrex (Pfizer Ltd) | |||||
| nabumetone | Not approved for prescribing | ||||
| Oral tablet | |||||
| Nabumetone (Non-proprietary) | |||||
| naproxen | Joint formulary choice | ||||
| Effervescent tablet | |||||
| Stirlescent (Stirling Anglian Pharmaceuticals Ltd) | |||||
| Gastro-resistant tablet | |||||
| Naproxen (Non-proprietary) | Joint formulary choice | ||||
| Naprosyn EC (Atnahs Pharma UK Ltd) | Joint formulary choice | ||||
| Nexocin EC (Noumed Life Sciences Ltd) | |||||
| Oral suspension | |||||
| Naproxen (Non-proprietary) | Joint formulary choice | ||||
| Oral tablet | |||||
| Naproxen (Non-proprietary) | |||||
| Naprosyn (Atnahs Pharma UK Ltd) | |||||
| penicillamine | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral tablet | |||||
| Penicillamine (Non-proprietary) | |||||
| piroxicam | Joint formulary choice | ||||
|
Oral piroxicam is not approved for prescribing
Piroxicam capsules and oral dispersible tablets are not approved for prescribing. Topical piroxicam can be prescribed for pain. |
|||||
| Orodispersible tablet | |||||
| Feldene Melt (Pfizer Ltd) | Not approved for prescribing | ||||
| Oral capsule | |||||
| Piroxicam (Non-proprietary) | |||||
| Feldene (Pfizer Ltd) | |||||
| Cutaneous gel | |||||
| Piroxicam (Non-proprietary) | |||||
| risankizumab | Hospital only |
NICE TA596 NICE TA803 NICE TA888 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Skyrizi (AbbVie Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Skyrizi (AbbVie Ltd) | |||||
| rituximab | Hospital only |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| MabThera (Roche Products Ltd) | |||||
| Solution for infusion | |||||
| MabThera (Roche Products Ltd) | Hospital only | ||||
| Rixathon (Sandoz Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Ruxience (Pfizer Ltd) | |||||
| Truxima (Celltrion Healthcare UK Ltd) | Hospital only | ||||
|
Biosimilar
Truxima is the preferred biosimilar brand of rituximab for non-malignancy indications |
|||||
| sarilumab | Hospital only |
NICE TA485 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Kevzara (Sanofi) | Hospital only | ||||
| secukinumab | Hospital only |
NICE TA350 NICE TA407 NICE TA719 NICE TA445 NICE TA935 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Cosentyx (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| sulfasalazine | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Gastro-resistant tablet | |||||
| Sulfasalazine (Non-proprietary) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Salazopyrin EN (Pfizer Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral suspension | |||||
| Sulfasalazine (Non-proprietary) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Suppository | |||||
| Salazopyrin (Pfizer Ltd) | Not approved for prescribing | ||||
| Oral tablet | |||||
| Sulfasalazine (Non-proprietary) | |||||
| Salazopyrin (Pfizer Ltd) | |||||
| sulindac | Not approved for prescribing | ||||
| Oral tablet | |||||
| Sulindac (Non-proprietary) | |||||
| tenoxicam | Not approved for prescribing | ||||
| tiaprofenic acid | Not approved for prescribing | ||||
| Oral tablet | |||||
| Surgam (Beaumont Pharma Ltd) | |||||
| tocilizumab | Hospital only |
NICE TA375 NICE TA247 NICE TA518 NICE TA878 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
NICE TA518 - Tocilizumab for the treatment of Giant Cell Arteritis in adults
Non-formulary at HUHFT. Hospital only for providers that have this on their formulary The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE TA518.
|
|||||
| Solution for injection | |||||
| RoActemra (Roche Products Ltd) | Hospital only | ||||
| Tyenne (Fresenius Kabi Ltd) | |||||
| Solution for infusion | |||||
| RoActemra (Roche Products Ltd) | Hospital only | ||||
| Tyenne (Fresenius Kabi Ltd) | |||||
| tofacitinib | Hospital only |
NICE TA480 NICE TA543 NICE TA920 NICE TA547 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Modified-release tablet | |||||
| Xeljanz (Pfizer Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Xeljanz (Pfizer Ltd) | Hospital only | ||||
| upadacitinib | Hospital only |
NICE TA665 NICE TA744 NICE TA768 NICE TA829 NICE TA861 NICE TA814 NICE TA856 NICE TA905 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Modified-release tablet | |||||
| Rinvoq (AbbVie Ltd) | Hospital only | ||||
| ustekinumab | Hospital only |
NICE TA180 NICE TA340 NICE TA456 NICE TA633 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Solution for injection | |||||
| Stelara (Janssen-Cilag Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Stelara (Janssen-Cilag Ltd) | Hospital only | ||||
| Musculoskeletal system / Neuromuscular disorders | |||||
| riluzole | Shared care guideline |
NICE TA20 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Orodispersible film | |||||
| Emylif (Zambon UK Ltd) | |||||
| Oral suspension | |||||
| Teglutik (Martindale Pharmaceuticals Ltd) | Shared care guideline | ||||
| Oral tablet | |||||
| Riluzole (Non-proprietary) | |||||
| Musculoskeletal system / Muscular dystrophy | |||||
| ataluren | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE HST22 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Granules for oral suspension | |||||
| Translarna (PTC Therapeutics Ltd) | |||||
| nusinersen | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA588 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Spinraza (Biogen Idec Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| risdiplam | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA755 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral solution | |||||
| Evrysdi (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Musculoskeletal system / Myasthenia gravis and Lambert-Eaton myasthenic syndrome | |||||
| amifampridine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral tablet | |||||
| Firdapse (SERB) | |||||
| eculizumab |
NICE HST1 |
||||
| Solution for infusion | |||||
| Bekemv (Amgen Ltd) | |||||
| Epysqli (Samsung Bioepis NL B.V. Ltd) | |||||
| Soliris (Alexion Pharma UK Ltd) | |||||
| efgartigimod alfa | |||||
| Solution for infusion | |||||
| Vyvgart (Argenx UK Ltd) | |||||
| neostigmine | Not approved for prescribing | ||||
| Solution for injection | |||||
| Neostigmine (Non-proprietary) | |||||
| pyridostigmine bromide | Not approved for prescribing | ||||
| Oral solution | |||||
| Pyridostigmine bromide (Non-proprietary) | |||||
| Oral tablet | |||||
| Pyridostigmine bromide (Non-proprietary) | |||||
| Mestinon (Viatris UK Healthcare Ltd) | |||||
| rozanolixizumab | |||||
| Solution for infusion | |||||
| Rozanolixizumab (Non-proprietary) | |||||
| zilucoplan | |||||
| Solution for injection | |||||
| Zilbrysq (UCB Pharma Ltd) | |||||
| Musculoskeletal system / Nocturnal leg cramps | |||||
| quinine | Joint formulary choice | ||||
| Oral tablet | |||||
| Quinine (Non-proprietary) | |||||
| Musculoskeletal system / Myotonic disorders | |||||
| mexiletine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA748 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral capsule | |||||
| Mexiletine (Non-proprietary) | |||||
| Namuscla (Lupin Healthcare (UK) Ltd) | |||||
| Musculoskeletal system / Spasticity | |||||
| baclofen | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Baclofen (Non-proprietary) | Specialist knowledge/initiation | ||||
| Lioresal (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Lyflex (Rosemont Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Baclofen (Non-proprietary) | Hospital only | ||||
| Lioresal (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Baclofen (Non-proprietary) | Hospital only | ||||
| Lioresal (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Baclofen (Non-proprietary) | |||||
| Lioresal (Novartis Pharmaceuticals UK Ltd) | |||||
| cannabis extract | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Shared Care prescribing for patients initiated on treatment by the National Hospital for Neurology and Neurosurgery
NICE NG144 recommends Sativex® for severe treatment refractory multiple sclerosis related spasticity, initiated by a spasticity specialist which may be continued under a shared care agreement by non-specialists in primary care. This service is not provided at Homerton therefore it has a hospital only status, but if your patient has been referred to the National Hospital for Neurology and Neurosurgery (NHNN) there is an approved Shared Care Guideline to support the transfer of prescribing of Sativex® to primary care. |
|||||
| Spray | |||||
| Sativex (GW Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Shared Care prescribing for patients initiated on treatment by the National Hospital for Neurology and Neurosurgery
NICE NG144 recommends Sativex® for severe treatment refractory multiple sclerosis related spasticity, initiated by a spasticity specialist which may be continued under a shared care agreement by non-specialists in primary care. This service is not provided at Homerton therefore it has a hospital only status, but if your patient has been referred to the National Hospital for Neurology and Neurosurgery (NHNN) there is an approved Shared Care Guideline to support the transfer of prescribing of Sativex® to primary care. |
|||||
| dantrolene sodium | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Powder for solution for injection | |||||
| Dantrium (Forum Health Products Ltd) | Hospital only | ||||
| Oral capsule | |||||
| Dantrium (Forum Health Products Ltd) | |||||
| diazepam | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral suspension | |||||
| Diazepam (Non-proprietary) | Joint formulary choice | ||||
| Oral solution | |||||
| Diazepam (Non-proprietary) | Joint formulary choice | ||||
| Solution for injection | |||||
| Diazepam (Non-proprietary) | |||||
| Enema | |||||
| Diazepam (Non-proprietary) | |||||
| Oral tablet | |||||
| Diazepam (Non-proprietary) | |||||
| methocarbamol | Not approved for prescribing | ||||
| Oral tablet | |||||
| Methocarbamol (Non-proprietary) | |||||
| Robaxin (Almirall Ltd) | |||||
| pridinol | |||||
| tizanidine | Not approved for prescribing | ||||
| Oral tablet | |||||
| Tizanidine (Non-proprietary) | |||||